FindTrial
Sign In

iron sulphate

DRUG5 trials

Sponsors

Pharmacosmos A/S, University of Turin, Italy, Swiss Federal Institute of Technology

Conditions

Bronchial DiseaseChemotherapy Induced AnaemiaChronic Kidney DiseaseCoughInflammatory Bowel DiseaseIron DeficiencyIron Deficiency AnemiaLaryngeal Disease

Phase 3

Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
CompletedNCT01017614
Pharmacosmos A/SInflammatory Bowel Disease
Start: 2009-10-31End: 2012-08-31Target: 350Updated: 2012-11-27
Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
CompletedNCT01102413
Pharmacosmos A/SChronic Kidney Disease, Iron Deficiency Anemia
Start: 2010-04-30End: 2014-06-30Updated: 2015-12-03
A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
CompletedNCT01145638
Pharmacosmos A/SChemotherapy Induced Anaemia, Non-myeloid Malignancies
Start: 2010-10-31End: 2014-05-31Updated: 2015-12-03

Unknown Phase

Iron Repletion in Chronic Cough and Iron Deficiency
CompletedNCT01507792
University of Turin, ItalyBronchial Disease, Cough, Iron Deficiency +1
Start: 2002-01-31End: 2011-01-31Updated: 2012-01-11
Evaluation of the Effects of an Exogenous Phytase on Iron Absorption From LNS Added to Complementary Foods
CompletedNCT01991626
Swiss Federal Institute of TechnologyIron Deficiency
Start: 2013-09-30End: 2014-08-31Updated: 2015-09-23

Related Papers

The effect of lipids, a lipid-rich ready-to-use therapeutic food, or a phytase on iron absorption from maize-based meals fortified with micronutrient powders.
2017-05-037 citations